| Mrs Cassandra Elizabeth Arpin, APRN | |
|
383 Old Colchester Rd, Amston, CT 06231-1623 | |
| (860) 303-0433 | |
| Not Available |
| Full Name | Mrs Cassandra Elizabeth Arpin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 383 Old Colchester Rd, Amston, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205461480 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 134698 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| William W Backus Hospital | Norwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The William W Backus Hospital | 0749170645 | 178 |
News Archive
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Mesa Laboratories, Inc. today reported a fifty percent increase in revenue for the fiscal first quarter ended June 30, 2010.
Using a novel polymer that becomes unstable under the pH conditions inside tumor cells, investigators at Singapore's Institute of Bioengineering and Nanotechnology have developed a core-shell nanoparticle targeted to deliver drugs to tumors.
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
› Verified 8 days ago
| Entity Name | Windham Community Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023191467 PECOS PAC ID: 2961309059 Enrollment ID: O20031217000231 |
News Archive
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Mesa Laboratories, Inc. today reported a fifty percent increase in revenue for the fiscal first quarter ended June 30, 2010.
Using a novel polymer that becomes unstable under the pH conditions inside tumor cells, investigators at Singapore's Institute of Bioengineering and Nanotechnology have developed a core-shell nanoparticle targeted to deliver drugs to tumors.
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
› Verified 8 days ago
| Entity Name | Natchaug Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295811321 PECOS PAC ID: 5395648737 Enrollment ID: O20040202000008 |
News Archive
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Mesa Laboratories, Inc. today reported a fifty percent increase in revenue for the fiscal first quarter ended June 30, 2010.
Using a novel polymer that becomes unstable under the pH conditions inside tumor cells, investigators at Singapore's Institute of Bioengineering and Nanotechnology have developed a core-shell nanoparticle targeted to deliver drugs to tumors.
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
› Verified 8 days ago
| Entity Name | The William W Backus Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467517235 PECOS PAC ID: 0749170645 Enrollment ID: O20040316000739 |
News Archive
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Mesa Laboratories, Inc. today reported a fifty percent increase in revenue for the fiscal first quarter ended June 30, 2010.
Using a novel polymer that becomes unstable under the pH conditions inside tumor cells, investigators at Singapore's Institute of Bioengineering and Nanotechnology have developed a core-shell nanoparticle targeted to deliver drugs to tumors.
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cassandra Elizabeth Arpin, APRN 383 Old Colchester Rd, Amston, CT 06231-1623 Ph: (860) 303-0433 | Mrs Cassandra Elizabeth Arpin, APRN 383 Old Colchester Rd, Amston, CT 06231-1623 Ph: (860) 303-0433 |
News Archive
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Mesa Laboratories, Inc. today reported a fifty percent increase in revenue for the fiscal first quarter ended June 30, 2010.
Using a novel polymer that becomes unstable under the pH conditions inside tumor cells, investigators at Singapore's Institute of Bioengineering and Nanotechnology have developed a core-shell nanoparticle targeted to deliver drugs to tumors.
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.
Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and the largest exporter by volume in the medical dressing industry in China, today announced that the Company received approval to list its common stock on NYSE Amex.
› Verified 8 days ago
Mrs. Melissa Marie Bartolotta, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 410 Old Colchester Rd, Amston, CT 06231 Phone: 860-372-1095 | |
Mr. Alex Joseph Rarey, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 80 Hillcrest Dr, Amston, CT 06231 Phone: 860-798-7443 |